{
    "Trade/Device Name(s)": [
        "VARIANT\u2122 II TURBO HbA1c Kit - 2.0"
    ],
    "Submitter Information": "Bio-Rad Laboratories, Inc.",
    "510(k) Number": "K130990",
    "Predicate Device Reference 510(k) Number(s)": [
        "K122472"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP"
    ],
    "Summary Letter Date": "May 9, 2013",
    "Summary Letter Received Date": "April 10, 2013",
    "Submission Date": "April 5, 2013",
    "Regulation Number(s)": [
        "21 CFR 864.7470"
    ],
    "Regulation Name(s)": [
        "Glycosylated hemoglobin assay"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "VARIANT II TURBO Hemoglobin Testing System"
    ],
    "Method(s)/Technology(ies)": [
        "Ion-exchange high performance liquid chromatography (HPLC)"
    ],
    "Methodologies": [
        "Chromatography"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Bio-Rad VARIANT II TURBO HbA1c Kit - 2.0 assay using HPLC for quantitative determination of hemoglobin A1c in whole blood",
    "Indications for Use Summary": "Quantitative determination of hemoglobin A1c in human whole blood to monitor long-term glycemic control in individuals with diabetes mellitus, for professional use only",
    "fda_folder": "Hematology"
}